BNP Paribas has increased its price target for Keurig Dr Pepper to $36 from $29 following the company's Q3 2026 earnings report. This adjustment indicates a more positive analyst outlook despite challenges in the U.S. coffee segment, suggesting potential upside for the stock.
BNP Paribas raised its price target on Keurig Dr Pepper (KDP) to $36 from $29. This revision comes after KDP's Q3 2026 earnings report, which, despite highlighting difficulties in its U.S. coffee segment, saw the company maintain its full-year outlook. The increased price target suggests that BNP Paribas analysts see underlying strength or future potential in KDP that outweighs recent segment-specific challenges. This is a moderately positive signal for KDP shareholders, as it reflects improved analyst sentiment and could attract new investors. In the short term, this could lead to a modest bump in KDP's stock price, while long-term implications depend on KDP's ability to execute on its maintained outlook and address coffee segment issues. A key opportunity for traders is to consider if this price target adjustment signals a broader positive re-evaluation of KDP's market position.